Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2-early breast cancer: WSG-AGO EC-Doc Trial

DSpace Repository

Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2-early breast cancer: WSG-AGO EC-Doc Trial

Author: Gluz, O.; Liedtke, C.; Huober, J.; Peyro-Saint-Paul, H.; Kates, R. E.; Kreipe, H. H.; Hartmann, A.; Pelz, E.; Erber, R.; Mohrmann, S.; Moebus, V.; Augustin, D.; Hoffmann, G.; Thomssen, C.; Jaenicke, F.; Kiechle, M.; Wallwiener, D.; Kuhn, W.; Nitz, U.; Harbeck, N.
Tübinger Autor(en):
Huober, Jens
Wallwiener, Diethelm
Published in: Annals of Oncology (2016), Bd. 27, H. 6, S. 1035-1040
Verlagsangabe: Oxford Univ Press
Language: English
Full text: http://dx.doi.org/10.1093/annonc/mdw070
ISSN: 1569-8041
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)